The prognostic role of endometriosis amongst women with ovarian clear cell carcinoma (OCCC) remains debatable. The aim of this study was to ascertain the effect of endometriosis on the prognosis of OCCC.
A retrospective review of the medical records of 94 women diagnosed and treated for OCCC at a tertiary gynaecological cancer centre in the UK, spanning the period 2010–2019. Women were divided into two groups according to the presence of endometriosis. Clinico-pathological characteristics, progression-free survival (PFS) and overall survival (OS) were collated between the two groups.
Forty-six cases of endometriosis-free OCCC (Ef-OCCC) were collated with 48 cases of endometriosis-related OCCC (Er-OCCC). There was no significant difference between the two groups regarding age (p-value = 0.2), FIGO stage (p-value = 0.8), residual disease (RD) (p-value = 0.07), adjuvant chemotherapy agent (p-value = 0.4) or chemo-resistance (p-value = 0.9). The presence of endometriosis did not significantly affect either OS or PFS. The median OS in the Ef-OCCC and Er-OCCC was 55.00 (95% CI 32.00–189.00) and 71.00 (95% CI 47.00–97.00; log rank = 1.35, p-value = 0.2) months. The median PFS in the Ef-OCCC and Er-OCCC group was 39.00 (95% CI 19.00–143.00) and 39.00 (95% CI 19.00–62.00; log rank = 0.7, p-value = 0.4) months. Survival differences between the two groups were not significant after stratification analysis for independent prognosticators.
Endometriosis was not independently associated with the prognosis of OCCC either in crude analysis or after stratification for stage and RD. Further larger, well-designed prospective studies are warranted to draw firmer conclusions on the intrinsic link between endometriosis and OCCC.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Brinton LA, Sahasrabuddle V, Trabert B (2013) Epidemiology of gynecologic cancers. In: Barakat RR, Berchuck A, Markman M et al (eds) Principles and practice of gynecologic oncology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1–29
Anglesio MS, Carey MS, Köbel M, Mackay H, Huntsman DG (2011) Vancouver ovarian clear cell symposium speakers. Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010. Gynecol Oncol 121:407–415
del Carmen MG, Birrer M, Schorge JO (2012) Clear cell carcinoma of the ovary: a review of the literature. Gynecol Oncol 126:481–490
Goff BA, de la Cuesta SR, Muntz HG et al (1996) Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 60:412–417
Winter WE 3rd, Maxwell GL, Tian C et al (2007) Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 25:3621–3627
Duska LR, Garrett L, Henretta M et al (2010) When ‘never-events’ occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes. Gynecol Oncol 116:374–377
Omura GA, Brady MF, Homesley HD et al (1991) Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol 9:1138–1150
King CM, Barbara C, Prentice A, Brenton JD, Charnock-Jones DS (2016) Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma. J Pathol 238:185–196
Soigliana E, Vigano P, Parazzini F, Stoppelli S, Giambattista E, Vercellini P (2006) Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecol Oncol 101:331–341
Hermens M, van Altena AM, Nieboer TE, Schoot BC, van Vliet HAAM, Siebers AG et al (2020) Incidence of endometriosis and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study. Am J Obstet Gynecol 107:e1-11
Kim HS, Kim TH, Song YS (2014) Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer 110(7):1878–1890
Kim HS, Kim MA, Lee M, Suh DH, Kim K, No JH et al (2015) Effect of endometriosis on the prognosis of ovarian clear cell carcinoma: a two-center cohort study and meta-analysis. Ann Surg Oncol 22:2738–2745
Samson JA (1925) Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg 10:1–72
Scott RB (1953) Malignant changes in endometriosis. Obstet Gynecol 2:283–289
Kondi-Pafiti A, Papakonstantinou E, Iavazzo C, Grigoriadis C, Salakos N, Gregoriou O (2012) Clinicopathological characteristics of ovarian carcinomas associated with endometriosis. Arch Gynecol Obstet 285:479–483
Erzen M, Rakar S, Klancnik B, Syrjänen K (2001) Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol 83:100–108
Scarfone G, Bergamini A, Noli S, Villa A, Cipriani S, Taccagni G, Vigano P et al (2014) Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Gynecol Oncol 133:480–484
Kumar S, Munkarah A, Arabi H, Bandyopadhyay S, Semaan A, Hayek K, Garg G et al (2011) Prognostic analysis of ovarian cancer associated with endometriosis. Am J Obstet Gynecol 204(63):e1-7
Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM et al (2012) Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 13:385–394
Heidemann LN, Hartwell D, Heidemann CH, Jochumsen KM (2014) The relation between endometriosis and ovarian cancer—a review. Acta Obstet Gynecol Scand 93:20–31
Hermens M, van Altena AM, Nieboer TE, Schoot BC, van Vliet HAAM, Siebers AG, Bekkers RLM (2020) Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study. Am J Obstet Gynecol 223:107.e1-107.e11
Tay SK, Cheong MA (2014) Evidence for ethnic and environmental contributions to frequency of ovarian clear cell carcinoma. Just N Z J Obstet Gynaecol 54:225–230
Chan JK, Teoh D, Hu JM et al (2008) Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 109:370–376
Kurman RJ, Shih IM (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34:433–443
Bulun SE, Wan Y, Matei D (2019) Epithelial mutations in endometriosis: link to ovarian cancer. Endocrinology 160:626–638
Saavalainen L, Lassus H, But A, Tiitinen A, Harkki P, Gissler M, Pukkala E, Heikinheimo O (2018) Risk of gynecologic cancer according to the type of endometriosis. Obstet Gynecol 131:1095–1102
Gadducci A, Lanfredini N, Tana R (2014) Novel insights on the malignant transformation of endometriosis into ovarian carcinoma. Gynecol Endocrinol 30(9):612–617
Paik ES, Kim TJ, Choi CH, Kim BG, Bae DS, Lee JW (2018) Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis. J Gynecol Oncol 29(2):e18
Scarfone G, Bergamini A, Noli S, Villa A, Cipriani S, Taccagni G, Vigano P et al (2014) Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Gynecol Oncol 133(3):480–484
Zhao T, Shao Y, Liu Y, Wang X, Guan L, Lu Y (2018) Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute. J Ovarian Res 11(1):53
Bai H, Cao D, Yuan F, Sha G, Yang J, Chen J, Wang Y et al (2016) Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: experiences at three academic institutions. Gynecol Oncol 143:526–531
Schnack TH, Høgdall E, Thomsen LN, Høgdall C (2017) Demographic, clinical, and prognostic factors of ovarian clear cell adenocarcinomas according to endometriosis status. Int J Gynecol Cancer 27:1804–1812
Ju UC, Kang WD, Kim SM (2019) The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma. Int J Gynaecol Obstet 146:177–183
Cool B, Laverty CRA, Fortune DW (1975) Clear cell carcinoma of the ovary—clinical and pathological features. Aust N Z J Obstet Gynaecol 15:40–46
Crozier MA, Copeland LJ, Silva EG, Gershenson DM, Stringer CA (1989) Clear cell carcinoma of the ovary: a study of 59 cases. Gynecol Oncol 35:199–203
Komiyama S, Aoki D, Tominaga E, Susumu N, Udagawa Y, Nozawa S (1999) Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation. Gynecol Oncol 72:342–346
Kita T, Kikuchi Y, Kudoh K, Takano M, Goto T, Hirata J, Tode T et al (2000) Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary. Oncol Rep 7:327–331
Orezzoli JP, Russell AH, Oliva E, Del Carmen MG, Eichhorn J, Fuller AF (2008) Prognostic implication of endometriosis in clear cell carcinoma of the ovary. Gynecol Oncol 110:336–344
Veras E, Mao TL, Ayhan A, Ueda S, Lai H, Hayran M, Shih IEM et al (2009) Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol 33:844–853
Katagiri A, Nakayama K, Rahman MT, Rahman M, Katagiri H, Nakayama N, Ishikawa M et al (2012) Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma. Mod Pathol 25:282–288
Ye S, Yang J, You Y, Cao D, Bai H, Lang J, Chen J et al (2014) Comparative study of ovarian clear cell carcinoma with and without endometriosis in People’s Republic of China. Fertil Steril 102:1656–1662
Ishibashi H, Takano M, Miyamoto M, Soyama H, Matsuura H, Aoyama T, Yoshikawa T et al (2017) Role of endometriosis as a prognostic factor for post-progression survival in ovarian clear cell carcinoma. Mol Clin Oncol 7:1027–1031
Kawabata A, Yanaihara N, Nagata C, Saito M, Noguchi D, Takenaka M, Iida Y et al (2017) Prognostic impact of interleukin-6 expression in stage I ovarian clear cell carcinoma. Gynecol Oncol 146:609–614
Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH (2018) Significance of ovarian endometriosis on the prognosis of ovarian clear cell carcinoma. Int J Gynecol Cancer 28:11–18
Lee HY, Hong JH, Byun JH, Kim HJ, Baek SK, Kim JY, Kim KH et al (2020) Clinical characteristics of clear cell ovarian cancer: a retrospective multicenter experience of 308 patients in South Korea. Cancer Res Treat 52:277–283
Colombo N, Sessa C, du Bois A et al (2019) ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. Ann Oncol 30:672–705
Timmers PJ, Zwinderman AH, Teodorovic I et al (2009) Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial. Int J Gynecol Cancer 19:88–93
Oseledchyk A, Leitao MM, Konner J et al (2017) Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a surveillance, epidemiology, and end results cohort study, 2000–2013. Ann Oncol 28:2985–2993
Bogani G, Ditto A, Lopez S et al (2020) Adjuvant chemotherapy vs. observation in stage I clear cell ovarian carcinoma: a systematic review and meta-analysis. Gynecol Oncol 157:293–298
The authors would like thank Dr. Bindya Gupta for her invaluable support and clinical expertise. We would also like to thank the women whose details from the basis of this study and all members of the gynaecological MDT at Pan-Birmingham Gynaecological Cancer Centre.
The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.
Conflict of interest
The authors certify that no party has a direct interest in the results of the research and that no benefit will be conferred to us or any organisation with which we are associated.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tranoulis, A., Buruiana, F.H., Gupta, B. et al. Friend or foe? The prognostic role of endometriosis in women with clear cell ovarian carcinoma. A UK population-based cohort study. Arch Gynecol Obstet (2021). https://doi.org/10.1007/s00404-021-06191-8
- Ovarian clear cell carcinoma